Sign up to save your podcasts
Or
Share JAMA Oncology : Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD.
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD.
More shows like JAMA Network
View all
JAMA Editors' Summary
134 Listeners
Medicine and Science from The BMJ
41 Listeners
NEJM This Week
318 Listeners
Diabetes Core Update
107 Listeners
JAMA Clinical Reviews
498 Listeners
AFP: American Family Physician Podcast
687 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
Mayo Clinic Talks
281 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
JAMA Dermatology Author Interviews
17 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
12 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
6 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,105 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
368 Listeners
NEJM AI Grand Rounds
53 Listeners